PharmiWeb.com - Global Pharma News & Resources
27-Mar-2019

Anti-Osteoporosis Therapy and Fracture Healing Market is expected to reach around US$ 5,941 Mn by the end of 2026

VALLEY COTTAGE, N.Y. – Future Market Insights has recently published a report titled “Anti-Osteoporosis Therapy and Fracture Healing Market: Global Industry Analysis (2012 – 2017) and Opportunity Assessment (2018 – 2026).” The report states that despite the uncertainty in terms of political and economic scenario, the global healthcare industry is expected to receive a positive push from sectors such as medical imaging, in-vitro diagnostics, biotech and pharmaceuticals, and medical devices. Key markets across the world are facing an enormous rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits. A speedily multiplying geriatric population, growing prevalence of chronic ailments such as cancer and cardiac disease, rising awareness among patients and high investments in clinical innovation are a few of the factors that are impacting the performance of the global healthcare industry at present. As a result of these factors, the global anti-osteoporosis therapy and fracture healing market is expected to witness a CAGR of 5.0% between 2018 and 2026.

Growing Geriatric Population to Augur Adoption

Rising prevalence of osteoporosis is considered to be an important factor driving the global market, as the growing number of patients will also increase the demand for drugs and therapy. Furthermore, due to the absence of any substitutes such as surgery, demand for osteoporosis drugs is increasing constantly. According to the International Osteoporosis Foundation, almost 50% of the global bone fracture incidences would occur in the Asia Pacific region by 2050 end. A high occurrence and incidence rate of the disease is considered an important driver for the market. Furthermore, rising geriatric population is considered to be an important factor for the growth of the market in the coming years, although patent expiries of leading brands would considerably slow down the growth rate.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1008

Bisphosphonates to Lead Among Drug Types

The global anti-osteoporosis therapy and fracture healing market has been segmented on the basis of drug type into bisphosphonates, calcitonin, estrogen or hormone replacement therapy, biologics, and anabolics. Among these, bisphosphonates is expected to emerge dominant by the end of 2026 with a valuation of around US$ 5,941 Mn in the same year.

Companies to Fight for Patent Rights

Leading companies in the market are competing against each other to gain patent rights on the different novel drugs that are being introduced in the market. This is further expected to intensify competition in the global market in the long run. Some of the companies operating in the global anti-osteoporosis therapy and fracture healing market are Novartis, Johnson and Johnson, GlaxoSmithKline PLC, Roche, Pfizer, MERCK, and AMGEN, among others.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you:  https://www.futuremarketinsights.com/askus/rep-gb-1008

Bisphosphonates to be Key Drug Type in North America

The global anti-osteoporosis therapy and fracture healing market has been segmented on the basis of drug type into bisphosphonates, calcitonin, estrogen or hormone replacement therapy, biologics, and anabolics. Biophosphonates is expected to emerge as the most preferred drug type in North America owing to its benefits and price point. Moreover, bisphosphonates, estrogen therapy, and selective estrogen receptor modulators (SERMs) are considered core classes in the global osteoporosis drugs market. Nevertheless, as the drugs belonging to these classes were invented decades ago, patents of most of the molecules and formulations have already expired or scheduled to expire by 2020.

For more detailed information and insights on the global anti-osteoporosis therapy and fracture healing market, contact Future Market Insights analysts at press@futuremarketinsights.com

Buy this report @ https://www.futuremarketinsights.com/checkout/1008

More from Healthcare, Pharmaceuticals and Medical devices Market:

About Us
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us
Abhishek Budholiya
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremarketinsights.com
Blog: Market Research Blog
Website: https:www.futuremarketinsights.com

Editor Details

Last Updated: 27-Mar-2019